India, Dec. 30 -- Concord Drugs Ltd has received significant purchase orders from multiple domestic entities for the supply of pharmaceutical products during December 2025, the company said in a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015.
The aggregate value of the orders stands at approximately Rs 14.71 crore, which exceeds the materiality threshold prescribed under the company's policy and is expected to have a positive impact on its business operations.
The orders have been awarded by the following entities:
Tamil Nadu Medical Services Corporation (TNMSC) – 6 purchase orders
Directorate General of Health Services (DGHS) – Government Medical Stores Depots
Tamil Nadu Medical Services Corporation...